Watchlist Price Alert

Ovid Therapeutics Inc. (OVID)

NASDAQ: OVID · Real-Time Price · USD

0.32

0.01 (2.14%)

At close: Jun 06, 2025, 3:59 PM

0.33

3.71%

After-hours: Jun 06, 2025, 05:58 PM EDT

2.14% (1D)

Bid	0.31
Market Cap	22.82M
Revenue (ttm)	548K
Net Income (ttm)	-24.97M
EPS (ttm)	-0.34
PE Ratio (ttm)	-0.94
Forward PE	-0.47
Analyst	Buy

Ask	0.34
Volume	915,179
Avg. Volume (20D)	468,647
Open	0.33
Previous Close	0.31
Day's Range	0.31 - 0.33
52-Week Range	0.24 - 3.31
Beta	0.07

About OVID

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol OVID

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for OVID stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

3 weeks ago

+3.11%

Ovid Therapeutics shares are trading higher after ... Unlock content with Pro Subscription

News

3 weeks ago · zacks.com

Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates

Ovid Therapeutics (OVID) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.17 per share a year ago.

1 month ago · zacks.com

Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Ovid Therapeutics (OVID) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago · zacks.com

Ovid Therapeutics (OVID) Reports Q4 Loss, Lags Revenue Estimates

Ovid Therapeutics (OVID) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.22 per share a year ago.